A company called BioTrove, Inc. has filed to come public via an initial public offering this morning. It has applied to take the proposed ticker of "BTRV" on NASDAQ.
BioTrove has filed to sell up to $75 million in securities for filing purposes, although no share count nor pricing range has been indicated. Underwriters are listed as Piper Jaffray, Lazard Capital Markets, and Robert W. Baird.
BioTrove develops, manufactures and markets instruments and consumables for genomic analysis, high throughput screening, and for molecular diagnostics. Its two marketed systems, OpenArray and RapidFire, accelerate R&D and commercial progress across multiple fields, including drug discovery. agricultural science, food and water supply safety, and molecular diagnostics. It claims a company customer list of 20 biopharmaceuticals for its RapidFire, including 11 of the 15 largest based on global sales. Total service and product revenues were listed as $4.783 million for fiscal Dec-2007.
We frequently discuss IPO’s, back door plays into IPO’s, spin-offs, and more on our open email distribution list.
Jon C. Ogg
April 1, 2008
Jon Ogg produces the Special Situation Investing Newsletter and he can be reached at firstname.lastname@example.org; he does not own securities in the companies he covers.